What is the future of immunotherapy in multiple myeloma?

被引：22
|
作者：
Rasche, Leo [1 ,2 ]
Hudecek, Michael [1 ]
Einsele, Hermann [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany
[2] Univ Klinikum Wurzburg, Mildred Scheel Early Career Ctr, Wurzburg, Germany
来源：
BLOOD | 2020年 / 136卷 / 22期
基金：
欧盟地平线“2020”;
关键词：
T-CELL THERAPY; NATURAL-KILLER-CELLS; ANTIBODY; DEXAMETHASONE; EXPRESSION; LEUKEMIA;
D O I：
10.1182/blood.2019004176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The treatment of multiple myeloma (MM) is currently being redefined by humoral and cellular immunotherapies. For decades, there was limited belief in immune-based anti-MM therapy as a result of the moderate graft-versus-myeloma effect of allogeneic stem cell transplantation. Today, monoclonal antibodies comprise the new backbone of anti-MM therapy, and T-cell therapies targeting BCMA are emerging as the most potent single agents for MM treatment. Herein, we present our assessment of and vision for MM immunotherapy in the short and midterm.
引用
收藏
页码：2491 / 2497
页数：7
相关论文
共 50 条
  • [1] Immunotherapy strategies for multiple myeloma: the present and the future
    Locke, Frederick L.
    Nishihori, Taiga
    Alsina, Melissa
    Kharfan-Dabaja, Mohamed A.
    IMMUNOTHERAPY, 2013, 5 (09) : 1005 - 1020
  • [2] Present and Future of Immunotherapy in the Management of Multiple Myeloma
    Baljevic, Muhamed
    Holstein, Sarah A.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (07) : 403 - +
  • [3] Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
    Ackley, James
    Ochoa, Miguel Armenta
    Ghoshal, Delta
    Roy, Krishnendu
    Lonial, Sagar
    Boise, Lawrence H.
    CANCERS, 2021, 13 (19)
  • [4] Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
    Abramson, Hanley N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [5] Immunotherapy for multiple myeloma: Current status and future directions
    Ayed, Ayed O.
    Chang, Lung-Ji
    Moreb, Jan S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 399 - 412
  • [6] Immunotherapy in multiple myeloma
    Hutchins, Irene M.
    Schachter, Levanto G.
    Mahindra, Anuj K.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) : 109 - 116
  • [7] Immunotherapy of multiple myeloma
    Ruffini, PA
    Kwak, LW
    SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 260 - 267
  • [8] Immunotherapy in Multiple Myeloma
    Knop, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 245 - 245
  • [9] IMMUNOTHERAPY IN MULTIPLE MYELOMA
    Gleason, Charise
    Catamero, Donna D.
    SEMINARS IN ONCOLOGY NURSING, 2017, 33 (03) : 292 - 298
  • [10] Immunotherapy in Multiple Myeloma
    Soekojo, Cinnie Yentia
    Ooi, Melissa
    de Mel, Sanjay
    Chng, Wee Joo
    CELLS, 2020, 9 (03)
12345